AstraZeneca
-
Norges splashes $746.7m on Cambridge life sciences scheme
Norwegian investor pays $746.7m for a stake in Kendall Square
-
AstraZeneca’s Disc will cost a further £100m
The total bill for the Discovery Centre in Cambridge will be £1.1bn
-
AstraZeneca boosts King’s Cross with HQ expansion
Vaccine maker more than doubles office space in central London
-
AstraZeneca demands £19m in continued wrangle over Bristol site
Administrators for Avlon have said that claimants are likely to get 18p in the pound